Mol BW - Search Results

1

Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.

Pajkrt E, Mol BW, van Lith JM, Bleker OP, Bilardo CM. Pajkrt E, et al. Among authors: mol bw. Ultrasound Obstet Gynecol. 1998 Sep;12(3):156-62. doi: 10.1046/j.1469-0705.1998.12030156.x. Ultrasound Obstet Gynecol. 1998. PMID: 9793186 Free article. Clinical Trial.

2

Nuchal translucency measurement in normal fetuses.

Pajkrt E, Bilardo CM, Van Lith JM, Mol BW, Bleker OP. Pajkrt E, et al. Among authors: mol bw. Obstet Gynecol. 1995 Dec;86(6):994-7. doi: 10.1016/0029-7844(95)00310-N. Obstet Gynecol. 1995. PMID: 7501355

3

Human papillomavirus DNA after treatment of cervical dysplasia: low prevalence in normal cytologic smears.

Bollen LJ, Tjong-A-Hung SP, van der Velden J, Mol BW, Lammes FB, ten Kate FW, ter Schegget J, Bleker OP. Bollen LJ, et al. Among authors: mol bw. Cancer. 1996 Jun 15;77(12):2538-43. doi: 10.1002/(SICI)1097-0142(19960615)77:12<2538::AID-CNCR17>3.0.CO;2-T. Cancer. 1996. PMID: 8640703

4

Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.

Mol BW, Pajkrt E, van Lith JJ, Bilardo CM. Mol BW, et al. Br J Obstet Gynaecol. 1996 Oct;103(10):1051-2. doi: 10.1111/j.1471-0528.1996.tb09570.x. Br J Obstet Gynaecol. 1996. PMID: 8863715 No abstract available.

5

Ultrasound screening for fetal trisomies at 10-14 weeks' gestation.

Pajkrt E, Bilardo CM, van Lith JM, Mol BW, Hansson K, van Prooijen Knegt AC, Bleker OP. Pajkrt E, et al. Among authors: mol bw. Early Hum Dev. 1996 Dec 30;47 Suppl:S35-6. doi: 10.1016/s0378-3782(96)01816-6. Early Hum Dev. 1996. PMID: 9031837 No abstract available.

6

The diagnostic value of the triple test in the diagnosis of Down's syndrome.

Mol BW, Lok JJ, Voorn W, Pajkrt E, van Lith J, van der Meulen J. Mol BW, et al. Early Hum Dev. 1996 Dec 30;47 Suppl:S55-8. doi: 10.1016/s0378-3782(96)01821-x. Early Hum Dev. 1996. PMID: 9031842 No abstract available.

7

Screening for ectopic pregnancy in symptom-free women at increased risk.

Mol BW, Hajenius PJ, Ankum WM, Bossuyt PM, van der Veen F. Mol BW, et al. Obstet Gynecol. 1997 May;89(5 Pt 1):704-7. doi: 10.1016/s0029-7844(97)00101-4. Obstet Gynecol. 1997. PMID: 9166305

8

Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study.

Konijnenberg A, van der Post JA, Mol BW, Schaap MC, Lazarov R, Bleker OP, Boer K, Sturk A. Konijnenberg A, et al. Among authors: mol bw. Am J Obstet Gynecol. 1997 Aug;177(2):434-42. doi: 10.1016/s0002-9378(97)70212-6. Am J Obstet Gynecol. 1997. PMID: 9290465

9

Clearance of cervical human papillomavirus infection by treatment for cervical dysplasia.

Bollen LJ, Tjong-A-Hung SP, van der Velden J, Mol BW, Boer K, ten Kate FJ, Bleker OP, ter Schegget J. Bollen LJ, et al. Among authors: mol bw. Sex Transm Dis. 1997 Sep;24(8):456-60. doi: 10.1097/00007435-199709000-00003. Sex Transm Dis. 1997. PMID: 9293608

10

Weekly nuchal translucency measurements in normal fetuses.

Pajkrt E, de Graaf IM, Mol BW, van Lith JM, Bleker OP, Bilardo CM. Pajkrt E, et al. Among authors: mol bw. Obstet Gynecol. 1998 Feb;91(2):208-11. doi: 10.1016/s0029-7844(97)00658-3. Obstet Gynecol. 1998. PMID: 9469277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,608 results

Search Page

Filters